Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FJUX6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,544
Award facts
- Contract value 100% obligated
- $41,544.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $41,544 to DMS Pharmaceutical Group Inc. for BOTOX 200 Unit Vials on January 20, 2026, with an ultimate completion date of February 10, 2026. This firm fixed-price delivery order was issued without a set-aside designation, reflecting the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, is well-positioned to fulfill this requirement given its extensive experience distributing specialty pharmaceuticals and medical consumables to Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR and valued at $499.999 billion through December 31, 2036. The PPV-G GEN V represents a $30.3 billion government-wide acquisition strategy designed to establish regional prime vendor contractors supplying the full spectrum of pharmaceutical products—including branded and generic prescription drugs, biologics, and medical consumables—to support military healthcare operations globally. The delivery order for BOTOX aligns with DMS Pharmaceutical Group's established portfolio of specialty pharmaceutical products serving Department of Defense medical supply chain requirements.
Quick answers
Who was awarded contract SPE2DR26FJUX6?
SPE2DR26FJUX6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FJUX6 worth?
The government has obligated $41,544 on SPE2DR26FJUX6.
Is contract SPE2DR26FJUX6 an order under another contract?
Yes. SPE2DR26FJUX6 is a delivery order under SPE2DR25D9329, an indefinite delivery contract.
Was contract SPE2DR26FJUX6 competed?
The extent of competition for SPE2DR26FJUX6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award